Contrary to our expectations, our analysis did, however, reveal that patients with a stronger infiltration by CD8+ lymphocytes within the tumor cell compartment had a higher risk of disease progression (p = 0.031), showed a shorter PFS (215 months vs. not reached, p = 0.038), but not OS (130 vs. 313 months, p = 0.25) (Figure 9E,F). This evidence concerns the gene CD8A and neoplasm.